Form 4: Viemed Healthcare Executive Jerome Cambre Reports Share Transactions
SEC Form 4 Filing
Viemed Healthcare's Vice President of Sales, Jerome Cambre, reported multiple transactions involving common shares and restricted stock units, including vesting and tax withholdings.
Summary
- Jerome Cambre, Vice President of Sales at Viemed Healthcare, reported several transactions on January 17th and 18th, 2025.
- These transactions include the vesting of restricted stock units (RSUs) and phantom share units, as well as the withholding of shares to cover tax obligations.
- On January 17th, 8,525 RSUs vested, and 2,131 phantom share units vested.
- Also on January 17th, 3,039 shares were withheld for taxes at a price of $8.15 per share.
- On January 18th, 3,003 phantom share units vested.
- Additionally, on January 21st, 2025, Cambre was granted 35,155 RSUs and 8,789 phantom share units, both vesting over three years.
- After these transactions, Cambre's direct holdings include 79,943 common shares.
Sentiment
Score: 5
Explanation: The document is a neutral report of insider transactions, with no indication of positive or negative sentiment. It is a routine filing.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- The vesting schedules for RSUs and phantom share units, typically over three years, are standard practice in executive compensation packages.
- Tax withholding of shares upon vesting is a common method to cover tax obligations for equity-based compensation.
- Companies like ResMed and AdaptHealth also use similar equity-based compensation methods for their executives.
Stakeholder Impact
- The transactions reported in this document provide transparency to shareholders regarding executive compensation and share ownership.
- The tax withholding of shares may slightly reduce the number of shares available in the market.
Key Dates
| Date | Description |
|---|---|
| 01/17/2023 | Date of grant for some of the restricted stock units and phantom share units that vested on January 17, 2025. |
| 01/18/2022 | Date of grant for some of the phantom share units that vested on January 18, 2025. |
| 01/17/2025 | Date of multiple transactions including vesting of RSUs and phantom share units, and tax withholding. |
| 01/18/2025 | Date of vesting of phantom share units. |
| 01/21/2025 | Date of grant for new RSUs and phantom share units. |
| 01/22/2025 | Date the Form 4 was signed. |
| 01/17/2026 | First vesting date for some of the phantom share units. |
| 01/21/2028 | First vesting date for the RSUs and phantom share units granted on January 21, 2025. |
Keywords
Viemed Healthcare, insider trading, Form 4, stock options, restricted stock units, phantom share units, executive compensation, share transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.